Stephanie Wang - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Stephanie Wang's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Stephanie Wang
Verified
Science Journalist, Breaking Cancer News
Cambridge
Beats
Biography
Stephanie is a science writer for Breaking Cancer News, the magazine of Teen Cancer America. Stephanie previously served as the senior science & tech section editor of the Harvard Political Review and editor-in-chief of the Journal of Policy Analysis at the Institute for Youth in Policy.
Health , Cancer , Medicine , Science , Innovations
celebrities, self-publicists, influencers
Content
By Juan Bu, Stephanie Wang, Yejee Lee, Dan Li| Wiley Online Library Verified 1 INTRODUCTION Corporate social irresponsibility (CSI) incidents, including environmental pollution, human rights violations, and governance fraud, have garnered increasing research attention due to their severe threats to social stakeholders' legitimate claims (Lange & Washburn, 2012; Strike et al., 2006) and their profound impact on firms' financial performance and reputational standing (Kölbel et al., 2017; Liu et al., 2022).
By Stephanie Wang| Breaking Cancer News@ Disparities in women’s cancer prevention and treatment is a significant concern in global healthcare. While women account for half of the global population and a substantial proportion of cancer-related deaths, they often face unique challenges that contribute to these disparities. Lack of Funding and Clinical Trial Representation Among the most salient issues affecting women’s healthcare is the disproportionate lack of research funding.
Rapidly Progressive Idiopathic Pyoderma Gangrenosum in a Pediatric Patient Successfully Treated With Infliximab
By Nikhita Perry, Stephanie Wang, Robert Smith, Robert Duffy| Wiley Online Library Verified Pyoderma gangrenosum (PG) is a rare skin disorder with poorly understood pathophysiology. PG infrequently occurs in children, and approximately 4% of patients with PG are infants and children. First line therapy is topical and systemic corticosteroids, which typically yields rapid response. We report a case of rapidly progressive pediatric PG of unknown inciting cause that ultimately required multi-modal therapy with systemic and topical corticosteroids, high-dose infliximab, and colchicine.
Company Info
Breaking Cancer News